BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 8923867)

  • 21. Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.
    Maas KH; Chuan SS; Cook-Andersen H; Su HI; Duleba A; Chang RJ
    J Clin Endocrinol Metab; 2015 Jan; 100(1):293-300. PubMed ID: 25313914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
    Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a gonadotropin-releasing hormone analog on rabbit ovarian function.
    Zanagnolo V; Dharmarajan AM; Hesla J; Wallach EE
    Endocrinology; 1996 Dec; 137(12):5400-6. PubMed ID: 8940363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
    Jakubowicz DJ; Nestler JE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):556-60. PubMed ID: 9024253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
    Fauser BC; de Jong D; Olivennes F; Wramsby H; Tay C; Itskovitz-Eldor J; van Hooren HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):709-15. PubMed ID: 11836309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism.
    Ibañez L; Potau N; Virdis R; Zampolli M; Terzi C; Gussinyé M; Carrascosa A; Vicens-Calvet E
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1599-603. PubMed ID: 8501168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
    Koivunen RM; Morin-Papunen LC; Ruokonen A; Tapanainen JS; Martikainen HK
    Hum Reprod; 2001 Dec; 16(12):2546-51. PubMed ID: 11726572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
    Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
    Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
    Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
    Ibáñez L; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
    Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
    Nestler JE; Jakubowicz DJ
    N Engl J Med; 1996 Aug; 335(9):617-23. PubMed ID: 8687515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.
    Gonen Y; Balakier H; Powell W; Casper RF
    J Clin Endocrinol Metab; 1990 Oct; 71(4):918-22. PubMed ID: 2119392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D; Leigh A; Wilson C; Donaldson A; Franks S
    Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.
    Nestler JE; Jakubowicz DJ
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4075-9. PubMed ID: 9398716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
    Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
    Hayes FJ; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian 17 alpha-hydroxyprogesterone responses to GnRH analog testing in oligomenorrheic insulin-dependent diabetic adolescents.
    Virdis R; Zampolli M; Street ME; Vanelli M; Potau N; Terzi C; Ghizzoni L; Ibanez L
    Eur J Endocrinol; 1997 Jun; 136(6):624-9. PubMed ID: 9225726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human chorionic gonadotrophin stimulation test as a predictor of ovarian response and pregnancy in IVF cycles stimulated with GnRH agonist gonadotrophin treatment: a pilot study.
    Fábregues F; Iraola A; Casamitjana R; Carmona F; Balasch J
    Hum Reprod; 2012 Apr; 27(4):1122-9. PubMed ID: 22313871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.